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I. INTRQDUCTIBN 
Kibronccrirl is :r large cxrracellular protein made up 
of multiple copies of three types of homology units [l]. 
Segments hon~ologous with the so called type II do- 
mains of fibroncctin have been identified in a variety of 
proteins such as insulin-like growth factor II rcccp- 
tor/mannosc 6.phospha~ receptor [2,3], mannosc 
receptor [4), blood clotting factor XII [5], bovine 
seminal fluid proteins DDG109 and BSP A3 (fi,7], 72 
kDa and 92 kDa type IV collagenases [8,9], Since dme 
proteins do not appear to share a common binding 
spccificiry it seems likely that their type II domains may 
have different roles. Recently we have shown that 
isolated type II domains of fibronectin and PDC-109 
are capable of binding denatured collagen as well as 
hydrophobic ligands [lo]. However, no information is 
Type iV collagenases play a key role in matrix 
remodelling, degradation of basement membranes and 
available on the binding specificity of type 11 domains 
contribute to the metastatic potential of tumor cells 
Ill]. These enzymes are unique among mammalian 
of other proteins. 
metalloproteinases in displaying marked affinity for 
gelatin and collagens of the basement membrane. In the 
present work we show that the type II domains of the 72 
kDa type IV procollagenase have specific affinity for 
gelatin-Sepharose 4Rindicating that these domains are 
responsible for the collagen affinity of the protein. 
2. MATERIALS AND METFlC”)DS 
2. I. Murrrirrls 
Louis, USA). The E. co/i expression plasnid pmcd23 [ 121 was obtain- 
Rcxrrictian cnzymez wcrc purchnscd from BRL (Bethesda, MB, 
USA) and Biolaba (Beverly, MA, USA), Oligodeoxyribanuclea~ido 
etl franI Dr. P. Vcnctianer (Biological H.escarch Ccntcr, SW&, 
wcrr rynrhcrircd on a CRB GENESIS DNA synthcsizcr (Csmbridgc 
Research Biuchcmicalr, Cambridge, UK) with rhc phaaphotriester 
Hungary). 
nrcrhad nnd purified on MoneQ and MonoRPC colt~~tv~r using an 
LKB HPLC.~ 
Thr Ml3 sequencing kit used for tlirlruxy sequctlciny of cloned 
DffA fragments was from Amcrshnm fntcrnn~ional, [he Sire Directed 
Mutagenesis Kil was obtained from Bochringcr (Mannhcim, Ger- 
nlilnrl. Gclalin Scpliarosc 4B (Pharmncia) according to lhc instruc- 
iion; & IIIC manufacturer. 
2 I2, Phsm ids 
Plasmid pf3STlcoll, the l3luesctipr vector containing the cDNA in- 
sert of pGel 186,2 of 72 kDa type IV collngcnase in its Svrr~l Site [81 
wns obtained from Dr. G.1. Goldberg (Washington UnivcrsitY, St. 
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2,3. Cottsrrucriott of plasrtrid exprmittg zlte three /ype II dorrraitrs o,f 
type IV ~ollugettrise 
pBST4coll was digested with EcoRl awl @/iI and the 1.4 kb frag. 
mcnt corresponding to the N-terminal part of type IVcolhgenase (but 
lacking most of the hemopexin-like domain) was isolated by clectro. 
phoresis on 1% low melting agatose using the prolocol of Qiagen, 
Studio City, CA), The fragment was cloned into the EcoR1/BsmNI 
site of Ml3 mpl8 sequencing vector and the replicative form of the 
recombinant Ml3 mp18-G/6 was digested with Avull and Ball and 
the 558 bp fragment (nucleotides 613-l 170 of the cDNA coding for 
the three type II units) was isolated (Fig, I). The fragment was blunt- 
ended by filling in with DNA polymcrasc I Klenow fragment and was 
cloned into the Steal site of Ml3 mpl9. In recombinant clones (Ml3 
mp 19/123) the insert was found in both orientations, 
Single stranded DNA of Ml3 mp19/123 was mutagenized (Fig. 2) 
with the mutagenic oligodeoxyribonucleotide 5’GAACAGGCTTTA. 
CCCTTGGT3’ according to the gapped-duplex method [13] using a 
Site Directed Mutagenesis Kit (Boehringer, Mannheim, Germany). 
Mutant phages were identified by plaque hybridization and the muta- 
tion was verified by sequencing with the dideoxy chain termination 
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method {NI. The rcplicativc form of mu~:~penizctl Ml3 nrplWlZ3 
wets digcsrcd with &&-it, blunt-c&d then was digextctl with &&81 
and lignled with rl~cPvrtlI/~ce’ruRI~digr’rlctl expression vector pmcd23. 
By cloning the Insert into rhc Pnrll airc of rhc vccror thr 8. 
grlactoxidnrc parlion 0r rhi~ fusion prolein ix reduced to 37 rcsitlucs 
(121, 
f%c/reric/rin co/i cclis carrying recombinant pmed23 plarmids wcrc 
yrawn, expression of /3-yaiaclosidasc fusion proteins was induced 
with 101) pM IPTG and fusion products wcrc isolated csscntinlly as 
described previously (IO]. Briefly, [hc IPTS-induced cells wcrc 
harvested by cemrifuyation at 4’C nnd the pcllcr was wnshcd with ior 
cold 25 mM Tris-HCI, 10 mM EDTA, 50 rr)M glucouc, pH &LO nrrd 
centrifuged at 4OC, The pclict was suspcndcd in the same buffer cw 
taining 1 mg/ml of lysoryme and incubated at 0% for IO min. The 
CCIIS were disrrlpted with nn MSE ultmsonicntor, the inclusion bodies 
were collected by centrifugation and then washed with the above buf- 
fer. The pellet comaining the inclusion bodies was dissolved in 0, I M 
Tris-HCI, 6 M guanidinium chloride buffer. pH 8.0 containing 100 
mM dithiothrcitol and was incubated at 25°C for 1 h will1 constant 
stirrings Insoluble cellular debris were removed by ccmrifuyation and 
the solution was gel.filtered on a Sephadcx G-25 column cquilibratcd 
with 0.1 M Tris-HCI, 3 M urea, 5 mM EDTA pH 8.0 to remove rlrc 
reducingagcnl. The fractions containing the protein were pooled, and 
3611 IB’, $70 
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Fig. 2. Introduction of a stop codon at the bcundary separating the 
third type II domain from the zinc-binding motif of 72 kDa type IV 
collagenase, The amino acid sequence [l] of the pertinent region of 
human fibronectin (fn), the amino acid and nucleotidc sequences [S] 
of human 72 ItDa type IV procollagenase (col) and the sequence of the 
mutagenic primer are shown: the site of mutagenesis i  marked by an 
asterisk. The 5uiI site used in the construction of expression vector 
pmed23/123 is also shown. The first 8 residues of the segment im- 
plicated in collagen binding by fibroncctin (161 are overlined. The 
numbers refer to the amino acid sequence of human 72 kDa type IV 
procollagenasc. 
24 
‘I% fibroncctin-horndog region of humnn 72 kT)a 
type IV pracollagenase has been expressed in E. cali as 
a B-galacroaidase Fusion product (fi-gal toll 123), 
isolated from inclusion bodies and refolded ascntinlly 
as described for the tygc Itt domains of Fibroncctin [IO]. 
The fusion protein consists of residues 1-37 OF & 
galactosidasc and residues 194-345 of the 72 kDa type 
IV coIlagcnasc. The calculated molecular mass, of the 
protein is 23 370 Da, 
We have found that using our refolding protocol [lo] 
a significant portion (80-9OTo) of the Fusion protein 
was. bound to gelatin-Scpharose 4B (Fig. 3A). When 
bound protein was desalted and reapplied onto a 
gelatin-Sepharosc 4B column complete rebinding was 
observed (Fig. 3B), supporting the specificity of the in- 
teraction. Furthermore, binding of the protein to 
gelatin-Sepharose 4B was shown to be specific for 
gelatin since no binding was observed when the protein 
was loaded onto unsubstituted Sepharosc 4B (Fig, 30 
The present data thus provide experimental support 
For the earlier suggestion that the Fibroncctin-like 
region of type IV collagenases might be responsible For 
the affinity of these metalloprotcinases forgelatin [8,9]. 
This suggestion was based on the fact that the 
homologous region is part of the collagen-binding do- 
main of fibronectin [1,8,9]. 
Previous studies on Fibronectin suggested that a 
14-residue segment C-terminal to its second type II do- 
main is critical for collagen binding [l6], As noted by 
Collier et al. [S], in this region a stretch of 4 residues 
(AAHE in Fig. 2) are shared by fibronectin and type IV 
collagenase. 
Some considerations, however, argue against a role 
of the AAHE sequence in collagen binding by type IV 
collagenases, First, a survey of the sequences of mam- 
malian metalloproteases [8,9] reveals that AAHE is pre- 
sent in all mammalian metaltoproteases although only 
type !Y procol!agenases have affinity for gelatin, Se- 
cond, AAI-IE is part of the conserved Zn2 + -binding site 
essential for catalysis by metalloproteases thus its in- 
volvement in gelatin binding would seem unlikely. 
Third, the exon-intron structure of the gene of type IV 
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Fig, 3. (A) Affinity chrumatagraphy of fusion protein &ysl call 123 
on ticlaIin&phnrosc 4D, The fusion protein was isolated and refold- 
ed ;IS describrd in the rcxr, The pr&ein was applied onta g~lnrin- 
Scpharosc 4B calrrnr~~s (l-ift lW30) equilibrated with 100 mM am- 
monium bicnrbonnrc buffer, pH 8.0 and the column was washed with 
the same buffer; rhc baund proteins wrrc clutcd with buffer contain. 
iny 8 M urea. The .rrrow marks the staff of clution with buffer con. 
tnininy 8 M urea, The inset shows I~cSDS-PAGE patterns afthc pro- 
tcins of 1PTG~induced bacteria (i), protein not bound (n) and bound 
(b) to gelatin-Scpharose 413 arid molecular mass markers (M), The 
numbers indicate the molecular masses of marker proteins. (8) Rem 
chromatography of fusion protrin @-gal roll 123 on gelntin~Scpharosc 
48. The bound protein from the first affinity chromt\tography step 
(Fig. 3A) was desalted in 100 mM ammonium bicarbonate, pH 8.0, 
reapplied onto n gelatin-Sepharosc 48 column (HR 10130) 
equilibrated with 10 mM ammonium bicnrbonntc buffer, pi-l 8.0 and 
the column was washed with the same buffer. The arrow marks the 
start ofelurion with buffer containing 8 M urea. (C)Chromatography 
of fusion protein P-gal coil 123 on Scpharosc 4B. The fusion protein 
in 100 mM ammonium bicarbonate, p1-i 8.0 was applied onto 
Sepharose 4B columns (HR 10130) equilibrated with 100 mM am- 
monium bicarbonate buffer, pH 8.0 and was washed with the same 
buffer. The arrow marks the start of elution with buffer containing 8 
M urea. 
collagenase clearly reveals that the AAHE sequence 
derives from the ancestral metalloprotease and not 
from the fibronectin-like ancestor [17] thus the presence 
of this tetrapeptide sequence in both type IV col- 
lagenase and fibronectin appears to be a coincidence. 
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